1. Academic Validation
  2. Discovery of podofilox as a potent cGAMP-STING signaling enhancer with antitumor activity

Discovery of podofilox as a potent cGAMP-STING signaling enhancer with antitumor activity

  • Cancer Immunol Res. 2023 Mar 15;CIR-22-0483. doi: 10.1158/2326-6066.CIR-22-0483.
Conggang Zhang 1 Jing Han 1 Shuiqing Hu 2 Yawei Hu 1 Yifang Xu 3 Yanfei Hou 3 Yinlong Yang 3 Huili Su 3 Zhengyin Zhang 3 Peng Liu 3 Xuxu Sun 4
Affiliations

Affiliations

  • 1 Tsinghua University, Beijing, China.
  • 2 UTSW, China.
  • 3 Tsinghua University, China.
  • 4 Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Abstract

Cyclic GMP-AMP (cGAMP) is a second messenger that activates the stimulator of interferon genes (STING) innate immune pathway to induce the expression of type I interferons (IFNs) and other cytokines. Pharmacological activation of STING is considered a potent therapeutic strategy in Cancer. In this study, we employed a cell-based phenotypic screen and identified podophyllotoxin (podofilox), a microtubule destabilizer, as a robust enhancer of the cGAMP-STING signaling pathway. We found that podofilox enhanced the cGAMP-mediated immune response by increasing STING-containing membrane puncta and the extent of STING oligomerization. Furthermore, podofilox changed the trafficking pattern of STING and delayed trafficking-mediated STING degradation. Importantly, the combination of cGAMP and podofilox had profound antitumor effects on mice by activating the immune response through host STING signaling. Together, these data provide insights into the regulation of cGAMP-STING pathway activation and demonstrate what we believe to be a novel approach for modulating this pathway and thereby promoting antitumor immunity.

Figures
Products
Inhibitors & Agonists